Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Locally administered AS ODN targeting a common cytokine receptor subunit for asthma

May 17, 2002

Bayer describes IkappaB kinase inhibitors as potential antiasthmatic agents

May 17, 2002

Dual CCR3 modulators/H1 antagonists designed at AstraZeneca

May 9, 2002

Design and SAR of new dual H1/H3 antagonists reported at ACS meeting

May 9, 2002

A new class of PDE4 inhibitors shows potential for the treatment of inflammatory lung diseases

May 7, 2002

Antiinflammatory compounds from GSK act by antagonizing the CCR3 receptor

May 6, 2002

IL-7, a potentially therapeutic cytokine for IPF

May 3, 2002

New series of peptide compounds synthesized at Enzyme Systems Products

May 2, 2002

CCR3 receptor antagonists jointly reported by Yamanouchi and Toray

May 2, 2002

Roflumilast proven safe and effective in exercise-induced asthma

May 2, 2002

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...